Pumonary Hypertension

Pulmonary Hypertension

Pulmonary hypertension (PH) is a condition characterized by elevated blood pressure in the arteries of the lungs, often leading to heart failure if left untreated. Preclinical research on PH involves various approaches to understand its pathophysiology and develop potential treatments. Animal models, particularly rodents and larger mammals, are commonly used to mimic PH conditions and study disease mechanisms. Researchers employ techniques such as hemodynamic measurements, right ventricular and pulmonary function, histology, and molecular analyses to assess pulmonary vascular remodeling, inflammation, and cardiac function in these models. Additionally, in vitro studies using cell cultures and ex vivo tissue preparations provide valuable insights into cellular and molecular pathways underlying PH progression. By combining these preclinical methods, scientists aim to uncover novel therapeutic targets and interventions to mitigate the devastating effects of pulmonary hypertension.

Related Products

Lung function phenotyping

Tissue Contractility & Relaxation

Langendorff & Working Heart

Platform for Precision Cut Lung Slices

Non-invasive Breathing Patterns

Implantable telemetry

Comprehensive and integrated assessment

In preclinical cardiopulmonary research, the challenge is often to link structural or physical changes (e.g. narrowing of pathways or build of up edema) to altered lung function measurements, such as resistance, compliance or spirometry outcomes. The flexiVent is a comprehensive tool allowing an integrated assessment of various disease determinants (e.g. extent and pattern of induced damage) on lung function decline. It measures the mechanical properties of the lungs with high sensitivity and reproducibility, providing clinically relevant outcomes.

Contractility measures simplified

Organ and tissue baths are used in pulmonary hypertension research, particularly for studying vascular reactivity and smooth muscle function in pulmonary arteries.

emkaBATH is designed for contractile measures in tissues such as aortic, tracheal, iliac, and papillary muscles, and/or microvessels such as veins, small arteries, and lymph vessels. The system provides heated, oxygenated, and nutrient-rich perfusate to the tissue with or without drug administration and electrical stimulation.

Tissue baths are widely used to study the effects of agonists and antagonists on tissue contractility. Dose-response curves allow for characterization of a drug’s pharmacological profile and the calculation of EC50 or Emax.

References & Publications

Perfusion system

As pulmonary hypertension is associated with heart diseases, the isolated perfused heart allows researchers to study contractility, relaxation, and electromechanical properties of the heart in a controlled environment.

Using either the Langendorff or the Working Heart technique, it allows the simultaneous assessment of cardiac electrophysiological and mechanical parameters (ECG, LVP, perfusion flow & pressure, etc.).

The isolated heart perfusion system provides highly reproducible experimental conditions to ensure survival of the isolated heart during several hours.

Automated microscopy and dosing platform

The physioLens enhances pulmonary hypertension research with high-throughput analysis of lung tissue from animals to humans. Its combination of brightfield and fluorescence microscopy, automated detection, and real-time contractility measurements enables precise studies of calcium dynamics and vascular responses. The perfusion setup ensures stable dosing and imaging. The added ability to measure cilia beating frequency provides new insights into airway and vascular health, advancing understanding of disease mechanisms and treatments.

Symptom screening

Whole-body plethysmography can be an easy tool for screening subjects quickly for preliminary respiratory data with the option of delivering inhaled therapeutics. Ventilatory parameters (e.g. breathing frequency, tidal volume, peak inspiratory or expiratory flows) can be measured noninvasively in conscious animals providing indicators of pulmonary changes in various cardiopulmonary models. IOX Software can seamlessly integrate pulmonary and cardio data for joint data collection and analysis.

vivoFlow+ plethysmograph can be combined with easyTEL+ implantable telemetry, providing synchronized neurologic and cardiorespiratory data.

Implantable telemetry

easyTEL+ implantable telemetry allows researchers to measure various hemodynamic parameters such as pulmonary artery pressure, mean arterial pressure, and right ventricular pressure, heart rate, stroke volume, and cardiac output. These measurements can provide valuable insights into the pathophysiology of PH and the effectiveness of potential therapies.

Activity levels can also be monitored, to evaluate the impact of PH on the animal’s mobility and quality of life.

Request a Free Custom Literature Search

Save time evaluating emka TECHNOLOGIES equipment by having an Application Specialist conduct a custom literature research.

Researchers will receive an email report showing emka TECHNOLOGIES publications relevant to their specific application research area, along with custom equipment recommendations and commentary.

By browsing this website, you accept the use of cookies for statistical purposes.

Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are set through our site by our advertising partners.

Google Adwords
We use Adwords to track our Conversions through Google Clicks.

Hubspot
We use Hubspot to monitor our traffic and to help us AB test new features.

Google Tag Manager

Save